---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-063143"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2022-03-02T23:59:59+00:00"
generated_at: "2026-06-27T02:17:49.091280+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad closes $1.2B senior notes offering (3.300% 2027 & 3.700% 2032)

## Summary
- $400M 3.300% notes due 2027 and $800M 3.700% notes due 2032 issued at par.
- Net proceeds of approximately $1.186 billion after underwriting discount and expenses.
- Proceeds for general corporate purposes, including working capital, capex, and potential M&A.
- Joint book-runners: Citigroup Global Markets, Goldman Sachs, J.P. Morgan Securities.
- Closing date March 2, 2022; offering pursuant to shelf registration statement on Form S-3.

## SEC filing metadata
- accession: 0001193125-22-063143
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2022-03-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000119312522063143/0001193125-22-063143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000119312522063143/d254235d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-063143
- JSON: https://secwatch.observer/filing/0001193125-22-063143.json
- Plain text: https://secwatch.observer/filing/0001193125-22-063143.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.